Supernus Pharmaceuticals
SUPN
SUPN
291 hedge funds and large institutions have $1.94B invested in Supernus Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 109 increasing their positions, 96 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
0% less funds holding
Funds holding: 292 → 291 (-1)
1.8% less ownership
Funds ownership: 107.73% → 105.93% (-1.8%)
10% less capital invested
Capital invested by funds: $2.15B → $1.94B (-$214M)
Holders
291
Holding in Top 10
2
Calls
$579K
Puts
$223K
Top Buyers
| 1 | +$17.1M | |
| 2 | +$14.1M | |
| 3 | +$11.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.57M |
| 5 |
JPMorgan Chase & Co
New York
|
+$6.93M |
Top Sellers
| 1 | -$39.1M | |
| 2 | -$15.3M | |
| 3 | -$10.7M | |
| 4 |
BlackRock
New York
|
-$10.3M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$6.85M |
